Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Filetti

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Recenti Progressi in Medicina|June 28, 2008
[Benign thyroid nodules: diagnostic and therapeutic approach]Cosimo Durante, Francesco Cava, Alessandra Paciaroni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2015
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literatureLivia Lamartina, Cosimo Durante, Sebastiano Filetti, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Endocrine|April 16, 2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinomaCosimo Durante, Alessandra Paciaroni, Katia Plasmati, et al.
Recenti Progressi in Medicina|January 27, 2007
[Cardiovascular disease and metabolic syndrome]Marianna Maranghi, Paola Coletta, Cosimo Durante, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 17, 2008
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfallsGiuseppe Costante, Cosimo Durante, Zélia Francis, et al.
Diabetes Care|July 22, 2016
When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin PumpOhad Cohen, Sebastiano Filetti, Javier Castañeda, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Oncology Letters|December 30, 2017
Effects of HuR downregulation on anaplastic thyroid cancer cellsLorenzo Allegri, Catia Mio, Diego Russo, et al.
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
F1000Research|February 6, 2018
Recent advances in managing differentiated thyroid cancerLivia Lamartina, Giorgio Grani, Cosimo Durante, et al.
Recenti Progressi in Medicina|June 28, 2008
[Benign thyroid nodules: diagnostic and therapeutic approach]Cosimo Durante, Francesco Cava, Alessandra Paciaroni, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2015
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literatureLivia Lamartina, Cosimo Durante, Sebastiano Filetti, et al.
Journal of Molecular Endocrinology|February 18, 2011
Epigenetics of thyroid cancer and novel therapeutic targetsDiego Russo, Giuseppe Damante, Efisio Puxeddu, et al.
Endocrine|April 16, 2013
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinomaCosimo Durante, Alessandra Paciaroni, Katia Plasmati, et al.
Recenti Progressi in Medicina|January 27, 2007
[Cardiovascular disease and metabolic syndrome]Marianna Maranghi, Paola Coletta, Cosimo Durante, et al.
Nature Clinical Practice. Endocrinology & Metabolism|December 17, 2008
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfallsGiuseppe Costante, Cosimo Durante, Zélia Francis, et al.
Diabetes Care|July 22, 2016
When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin PumpOhad Cohen, Sebastiano Filetti, Javier Castañeda, et al.
Trends in Endocrinology and Metabolism: TEM|March 14, 2008
Clinical implications of BRAF mutation in thyroid carcinomaEfisio Puxeddu, Cosimo Durante, Nicola Avenia, et al.
Oncology Letters|December 30, 2017
Effects of HuR downregulation on anaplastic thyroid cancer cellsLorenzo Allegri, Catia Mio, Diego Russo, et al.
Pageof 16